GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Natco Pharma Ltd (NSE:NATCOPHARM) » Definitions » Market Cap

Natco Pharma (NSE:NATCOPHARM) Market Cap : ₹265,342 Mil (As of Sep. 22, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Natco Pharma Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Natco Pharma's share price for the quarter that ended in Jun. 2024 was ₹1166.85. Natco Pharma's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 179 Mil. Therefore, Natco Pharma's market cap for the quarter that ended in Jun. 2024 was ₹208,995 Mil.

Natco Pharma's quarterly market cap increased from Dec. 2023 (₹145,321 Mil) to Mar. 2024 (₹170,522 Mil) and increased from Mar. 2024 (₹170,522 Mil) to Jun. 2024 (₹208,995 Mil).

Natco Pharma's annual market cap declined from Mar. 2022 (₹138,012 Mil) to Mar. 2023 (₹102,794 Mil) but then increased from Mar. 2023 (₹102,794 Mil) to Mar. 2024 (₹170,522 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Natco Pharma's Enterprise Value for Today is ₹251,422 Mil.


Natco Pharma Market Cap Historical Data

The historical data trend for Natco Pharma's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Natco Pharma Market Cap Chart

Natco Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 92,044.48 150,529.14 138,012.50 102,794.47 170,521.68

Natco Pharma Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 124,159.05 156,371.99 145,320.90 170,521.68 208,994.50

Competitive Comparison of Natco Pharma's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Natco Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Natco Pharma's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Natco Pharma's Market Cap distribution charts can be found below:

* The bar in red indicates where Natco Pharma's Market Cap falls into.



Natco Pharma Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Natco Pharma's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as

Market Cap (A: Mar. 2024 )=Share Price (A: Mar. 2024 )*Shares Outstanding (EOP) (A: Mar. 2024 )
=₹952.05*179.11
=₹170,522

Natco Pharma's Market Cap for the quarter that ended in Jun. 2024 is calculated as

Market Cap (Q: Jun. 2024 )=Share Price (Q: Jun. 2024 )*Shares Outstanding (EOP) (Q: Jun. 2024 )
=₹1166.85*179.11
=₹208,995

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Natco Pharma  (NSE:NATCOPHARM) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Natco Pharma Market Cap Related Terms

Thank you for viewing the detailed overview of Natco Pharma's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Natco Pharma Business Description

Traded in Other Exchanges
Address
Road No. 2, NATCO House, Banjara Hills, Hyderabad, TG, IND, 500034
Natco Pharma Ltd is a major drug manufacturing company. Natco aims to make specialty medicines accessible to all by manufacturing niche pharmaceutical products backed by its research and development capabilities. While the vast majority of the company's revenue is generated in India, the company looks internationally for growth opportunities. The company maintains a presence in Oncology and Hepatology treatment areas. Natco's active pharmaceutical ingredient segment APIs forms a core part of the company's business. The company operates in two different business segments: pharmaceuticals and agrochemicals. Within the pharma business segment, the company drives its sales through Finished Dosage Forms and Active Pharmaceutical Ingredients.

Natco Pharma Headlines

No Headlines